The result was similar to the previous reports in which RBM10 was found with a high mutation rate (16%) in radiological subsolid nodules25, and a high mutation rate (21%) in preinvasive and early-stage lung adenocarcinomas26. The gene discussed is RBM10; the disease is medical procedure.